UK AI Sovereign Fund Grant

On April 16, 2026, the UK Department for Science, Innovation, and Technology (DSIT) announced the first cohort of companies backed under the UK’s $675 million (£500 million) Sovereign AI program, marking the initial deployment of a fund designed to scale domestic AI capability in strategically important sectors.  In the short term, between 16 April 2026 and 5 June 2026, the Fund is offering grants of $1.3 million to $12 million to successful bids focused on high-value AI datasets and autonomous laboratory infrastructure. Subject to future approvals, the Fund intends to launch a larger Strategic Assets Programme with up to $215 million later in 2026.

The package combines targeted equity investment with in-kind support – most notably access to the UK’s AI Research Resource supercomputing capacity – to help early-stage firms accelerate R&D in the UK.  The initial beneficiaries span areas including AI-enabled drug discovery, advanced simulation, and infrastructure aimed at lowering the cost of compute, reflecting a dual focus on both frontier applications and enabling technologies.  

According to the UK Government, sovereign AI is “about leverage, not control”, with an acknowledgement that there is no UK tech stack without U.S. companies.  Indeed grants are open to UK-registered companies, research organisations, universities and consortia including non-UK companies.

U.S. companies have a worldwide reputation for innovative products, after-sales service, and training which makes them competitive in the UK market.  The United States and UK also share similar business cultures and business practices, which makes the UK an attractive market for U.S. AI capabilities.

To learn about how to participate in the Sovereign AI Strategic Assets Grants Programme, visit here.

For more information contact Claudia.Colombo@trade.gov.